Johnson & Johnson (JNJ) reported 21.89billioninrevenueforthequarterendedMarch2025,representingayear−over−yearincreaseof2.42.77 for the same period compares to 2.71ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof21.62 billion, representing a surprise of +1.26%. The company delivered an EPS surprise of +7.78%, with the consensus EPS estimate being $2.57.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...